The overseas epidemic has led to a leading foreign trade pharmaceutical company to break the start of the World Health Expo online trading platform | Wuhan_Sina Finance_Sina.com

Original title: The overseas epidemic has given rise to a leading foreign trade pharmaceutical company to make way for the World Health Expo online trading platform

After the crisis is an opportunity, as the pace of investment promotion accelerates, Wuhan, which has been through the battle against the new corona epidemic, is in the stage of economic recovery. At the same time, some pharmaceutical companies that are deeply involved in epidemic prevention and control have also seen significant growth in performance.Kyushu-dori(600998.SH) recently released its third quarterly report. The company achieved revenue of 80.3 billion yuan in the first three quarters, an increase of 9.46% year-on-year; net profit attributable to shareholders of publicly traded companies was 2.14 billion yuan, an increase of 110.23% year-on-year.

At the second activity of the “Longyang Lake Health” World Health Expo held recently, the “World Health Expo Online Trading Platform” was officially launched. With revenue of 99.5 billion yuan in 2019, Jointown, the largest private pharmaceutical distribution company in Hubei Province, became a figure that cannot be ignored at the event. Jointown said in an interview with a China Times reporter: Like all exhibitors, they can register on the platform, upload the qualification certificates required by the platform, and become a platform provider after passing the review. “

In addition to being active in its core business, Jointown is also looking for foreign investment opportunities. On November 14, Jointown announced its participation in the investment in Wuxi AstraZeneca CICC Venture Capital Partnership (Limited Partnership). He intends to invest 100 million RMB. The association will mainly carry out activities related to investment in domestic enterprises related to China’s health and medical industry. , To carry out the capital appreciation.

Pharmaceutical Business Leader in Wuhan

Jointown said in an interview with a China Times reporter: “Because the Health Expo platform is positioned as a ‘professional B2B business platform in the field of healthcare.’ For supply companies, through the Health Expo platform, you can find precise customers and expand the business. Influence, expand corporate sales channels and increase corporate sales; for purchasing companies, it can increase purchasing channels, strengthen purchasing management, and reduce purchasing costs. “

The journalist learned from the organizer that the aforementioned platforms have the dual function of “convention and exhibition services” and “online transactions”. They are committed to providing non-public medical institutions with tendering services, which can further promote market-oriented drug price reform and promote rationalization of drug prices.

Jointown is the largest private pharmaceutical distribution company in the country, ranked by revenueShanghai Pharmaceutical, China Resources Pharmaceutical is among the top 4 pharmaceutical trading companies in China. According to public data from 2017, the number of wholesale pharmaceutical companies in China is about 13,000, and the market share of major business revenue is 38%. Compared with the market share of more than 95% of the top three US pharmaceutical distribution companies, there is still much room for improvement in the concentration of China’s pharmaceutical industry.

Wuhan, which has passed the test of the epidemic, has continuously led to the signing of high-quality technological innovation projects with government support.In addition to Jointown, Abbott Trading (Shanghai) Co., Ltd., Shanghai Titaniumrobot、Dirui Medical, Qinghai Huanghai Pharmaceutical Co., Ltd., ZhejiangHuahai PharmaceuticalA total of six companies and the company’s top talent and industry leaders “Yellow Crane Talents” signed project contracts at the event site. At the same time, the Hanyang District People’s Government, various companies and prominent talents also signed collective agreements for 19 projects. Seven key projects, including the Wuhan branch of the State Key Laboratory of Respiratory Diseases Research-University-Production Base Project, the Pacific Insurance Financial Technology Research and Development Center Project, the Production Base Project of Ruiguang Kangtai Sphygmomanometer and Doctor Chunyu’s China Headquarters Project have signed contracts to settle in Hanyang.

According to the journalist’s on-site knowledge, including Siemens Medical, Philips Medical, General Electric (GE) Medical, Neusoft, Yuyue, Taikang,Robust medic、Infrared GaodeLeading brands and companies from the health industry participated in the Expo.

110% profit growth rate in the third quarter

Jointown’s net profit attributable to the parent company in the three quarters of this year has grown more than 110%, which has broken the record for the same period in previous years. Among them, the medical device business increased 34.89% compared to the same period last year. The company said the main reason was the rapid increase in the company’s sales of medical equipment and anti-epidemic materials during the reporting period due to the impact of domestic and foreign epidemics. In fact, in addition to the related business performance growth during the national epidemic, the export business design is an important highlight.

Jointown’s 2020 semi-annual report shows that “the company’s general agent, general distribution products, medical equipment, pharmaceutical e-commerce and other businesses have grown rapidly, gross profit margins have continued to increase, and the business of The company’s export and foreign trade has made historic progress. ” A China Times reporter said the company has been in the export business design since last year, but the outbreak of the new international crown epidemic has accelerated the company’s export business design, allowing the business of export achieve great development, thereby promoting the overall performance level. . According to the understanding of the Jointown reporter, in the second half of this year, the growth rate of the company’s export performance remained almost at the same level as the first half. Specific data will be reflected in the annual report 2020.

Jointown Express stated in the semi-annual report that in accordance with the ongoing epidemic of new foreign crowns and the strong market demand for medical supplies related to epidemic prevention, the company makes full use of the marketing equipment and facilities warehouses established abroad to integrate the supply chain of domestic medical supply production. The combination of the advantages of the system and the demand of the foreign market has accelerated the process of opening up foreign markets.

Specifically, from January to June this year, Jointown will export civilian masks, medical masks, goggles, medical masks, medical gloves, gowns, hand sanitizers, ventilators, and other medical materials and equipment for epidemic prevention, involving North America , the European Union, Australia, In more than ten countries in Latin America, the Middle East and East Asia, the accumulated value of exports, including taxes, reached 1,394 million yuan during the reporting period.

Since Jointown is based in Wuhan, it has several storage and logistics centers for pharmaceuticals and medical supplies located in Wuhan Dongxihu and other places. Jointown has played an important role in fighting the Wuhan epidemic, especially in the procurement, deployment, logistics and transportation of medical supplies.

In addition, research and development of the new national crown vaccine has entered the “last mile” of the third phase of the clinical sprint. Due to the high requirements of the new corona vaccine for cold chain transport conditions, the industry has recently been discussing whether the cold chain transport conditions of the new corona vaccine can meet the vaccine supply. The relevant person in charge of Jointown said in an interview with a China Times reporter on November 17 that Jointown has not yet started the cold chain transportation business of the new corona vaccine and is still communicating with partners that they need it, including the cold chain temperature. Some adjustments have been made to technical standards.

Editor in charge: Zhang Mei